Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$0.94 - $2.02 $1 - $4
2 New
2 $0
Q3 2022

Oct 25, 2022

SELL
$2.18 - $43.4 $327 - $6,510
-150 Reduced 42.86%
200 $17,000
Q4 2021

Jan 28, 2022

BUY
$4.32 - $6.27 $1,503 - $2,181
348 Added 17400.0%
350 $54,000
Q4 2019

Feb 12, 2020

BUY
$3.94 - $6.45 $7 - $12
2 New
2 $0

Others Institutions Holding SNOA

# of Institutions
1
Shares Held
2.27K
Call Options Held
0
Put Options Held
0

About Sonoma Pharmaceuticals, Inc.


  • Ticker SNOA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,100,940
  • Market Cap $8.87M
  • Description
  • Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...
More about SNOA
Track This Portfolio

Track Hbc Financial Services, Pllc Portfolio

Follow Hbc Financial Services, Pllc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbc Financial Services, Pllc, based on Form 13F filings with the SEC.

News

Stay updated on Hbc Financial Services, Pllc with notifications on news.